Grindwell Norton: The Unaudited Financial Results for the quarter and half year ended September 30, 2026
Grindwell Norton (GRINDWELL) filed a disclosure titled "The Unaudited Financial Results for the quarter and half year ended September 30, 2026". The company is valued at about ₹20,459 crore.
What happened
Grindwell Norton (GRINDWELL) filed a disclosure with the exchanges on 29 October 2026 at 02:16 PM titled "The Unaudited Financial Results for the quarter and half year ended September 30, 2026".
Company snapshot
Grindwell Norton is a small-cap company in the Capital Goods sector, with a market value of about ₹20,459 crore.
The stock last traded at ₹1,847.8, against a 52-week range of ₹1,329–₹2,455 (24.7% below the high).
Before this filing the shares had moved −6.7% over the month and −9.6% over three months. Average daily turnover over the last 20 sessions was about ₹7.98 crore.
Promoters held 58.03% at the end of Q1 FY27. Foreign institutions owned 5.21% and domestic institutions 19.59%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 703 | 94.5 | 8.53 |
| Q2 FY26 | 1,478 | 201.3 | 18.18 |
| Q3 FY26 | 753 | 95.2 | 8.6 |
| Q4 FY26 | 842 | 118.7 | 10.73 |
| Q1 FY27 | 803 | 115.5 | 10.43 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Across 300 similar disclosures by other Capital Goods companies, shares moved −0.3% on average the next day and +0.6% over five days; 46% of them rose the next day.
Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 29 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.